$106.830
+0.150 (+0.14%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
KYMR Prediction & Forecast by Similar Chart Analysis
Alphio's KYMR stock price prediction model matches the current Kymera Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $105.24 (-1.49%). The 1-week path is $108.55 (+1.61%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Kymera Therapeutics Inc Stock?
Kymera Therapeutics is a strong buy right now due to its current price of $112.4, which is significantly below the average analyst price target of $140, indicating a potential upside of 24.5%. Additionally, the stock has shown a year-to-date change of +54.48%, reflecting strong momentum. The main risk is the negative earnings per share (EPS) of -0.62 reported in the last quarter, which highlights ongoing losses, but the upcoming Phase 2b trial results for KT-621 could provide a substantial catalyst for price appreciation.
KYMR stock price ended at $106.83 on Wednesday, after rising +0.14%
Kymera Therapeutics Inc (KYMR) last closed at $106.83, gaining +0.14%. These facts feed the 1-day and 1-week KYMR price prediction above.
Forecast Drivers
Kymera Therapeutics Inc (KYMR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches KYMR, ranked by similarity.
Seasonality analysis for KYMR
Historically the probability of a positive October return for KYMR is 100.00%. July offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for KYMR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $28.11 | $29.73 | $33.03 | -72.17% |
| Nov 2026 | $27.33 | $31.25 | $33.15 | -70.74% |
| Dec 2026 | $19.49 | $26.59 | $33.21 | -75.11% |
In 2026, Kymera Therapeutics Inc (KYMR) is projected to range from $19.49 to $33.21.
Kymera Therapeutics Inc 2026 monthly forecast
In Oct 2026, Kymera Therapeutics Inc is projected to average $29.73, with a low of $28.11 and high of $33.03.
In Nov 2026, Kymera Therapeutics Inc is projected to average $31.25, with a low of $27.33 and high of $33.15.
In Dec 2026, Kymera Therapeutics Inc is projected to average $26.59, with a low of $19.49 and high of $33.21.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.